Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-044912
Filing Date
2013-08-13
Accepted
2013-08-13 08:15:56
Documents
10
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v351818_10q.htm 10-Q 530829
2 EXHIBIT 31.1 v351818_ex31-1.htm EX-31.1 9174
3 EXHIBIT 31.2 v351818_ex31-2.htm EX-31.2 9335
4 EXHIBIT 32.1 v351818_ex32-1.htm EX-32.1 9258
  Complete submission text file 0001144204-13-044912.txt   9833560

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT icpt-20130630.xml EX-101.INS 1124339
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE icpt-20130630_cal.xml EX-101.CAL 38995
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE icpt-20130630_def.xml EX-101.DEF 227637
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE icpt-20130630_lab.xml EX-101.LAB 338902
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE icpt-20130630_pre.xml EX-101.PRE 278168
10 XBRL TAXONOMY EXTENSION SCHEMA icpt-20130630.xsd EX-101.SCH 60574
Mailing Address 18 Desbrosses Street New York NY 10013
Business Address 18 Desbrosses Street NEW YORK NY 10013 646-747-1000
INTERCEPT PHARMACEUTICALS INC (Filer) CIK: 0001270073 (see all company filings)

EIN.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35668 | Film No.: 131031317
SIC: 2834 Pharmaceutical Preparations